XML 113 R50.htm IDEA: XBRL DOCUMENT v3.22.2
Business Combination - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended
May 19, 2022
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Business Acquisition [Line Items]            
Common stock, par value   $ 0.001   $ 0.001   $ 0.001
Acquisition related costs       $ 2,200,000    
Net revenue (loss)   $ (16,564,000) $ (21,754,000) (38,205,000) $ (44,840,000)  
Novosteo            
Business Acquisition [Line Items]            
Business acquisition, transaction costs $ 1,100,000          
Payment to acquire business $ 16,502,587          
Aggregate purchase of common stock shares 507,108          
Number of shares, Cancelled and converted 0.0911          
Common stock, par value $ 0.001          
Shares issued for acquisition 5,000,784          
Share price $ 3.30          
Unvested restricted shares 519,216          
Net revenue (loss)   $ 0   $ (100,000)